Laura Gault Sage Therapeutics, Inc. (SAGE) insider trading activity

SAGE Quotes by TradingView

Laura Gault is Chief Medical Officer of Sage Therapeutics, Inc.. Currently has a direct ownership of 34,649 shares of SAGE, which is worth approximately $253,630. The most recent transaction as insider was on Feb 13, 2025, when has been sold 685 shares (Common Stock) at a price of $7.18 per share, resulting in proceeds of $4,918. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.6K
222.71% 3M change
201.9% 12M change
Total Value Held $253,630

Laura Gault Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2025
SELL
Payment of exercise price or tax liability
$4,918 $7.18 p/Share
685 Reduced 1.94%
34,649 Common Stock
Jan 16 2025
BUY
Grant, award, or other acquisition
-
24,000 Added 40.45%
35,334 Common Stock
Aug 05 2024
SELL
Payment of exercise price or tax liability
$29,460 $8.96 p/Share
3,288 Reduced 23.44%
10,737 Common Stock
Aug 05 2024
BUY
Grant, award, or other acquisition
-
13,500 Added 49.05%
14,025 Common Stock
Feb 13 2024
BUY
Grant, award, or other acquisition
-
11,250 Added 49.5%
11,477 Common Stock
LG

Laura Gault

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SAGE